Cognition Therapeutics, Inc. is a discovery company developing disease modifying Alzheimer’s drugs. Located in Pittsburgh’s historic South Side, we are seeking highly motivated individuals to work in a dynamic small company environment. Cognition Therapeutics, Inc. is an equal opportunity employer.
Research Technician I, Biology – Part-time (8- 10 hrs. per week, can be in evening) The candidate will be a key contributor to a scientific research team discovering drugs to treat Alzheimer’s disease. Responsibilities include cleaning and maintenance of the company's instruments and facilities. Qualifications: - industry experience a plus - Excellent organizational, problem-solving and verbal/written communication skills - Demonstrated ability to work cooperatively in a fast paced multidisciplinary team environment
Physical Requirements: This position requires bending, squatting, climbing stairs; occasional pushing/pulling up to 31-60 pounds; reaching shoulder level and below; sitting, standing, walking, waist twisting, kneeling, crawling; occasional carrying/lifting of 31-60 pounds; gripping/grasping; repetitive hand and arm movements; controlled use of chemicals or toxic substances; latex and loud noise.
About Cognition Therapeutics
Cognition Therapeutics (CogRx) is a privately held biopharmaceutical company whose disease-relevant screening and novel chemistry platforms have produced a pipeline of disease modifying small molecule drug candidates which are being developed to treat Alzheimer’s disease and potentially other neurocognitive disorders. Cognition’s lead molecule, CT1812, is a proprietary first-in-class, orally available small molecule that is currently in clinical trials in patients with mild-to-moderate Alzheimer’s disease. This highly brain penetrant compound targets the sigma-2/PGRMC1 receptor complex, displacing toxic beta amyloid oligomers from their binding sites on brain cells and clearing them into the cerebrospinal fluid. CT1812 has been shown in multiple Alzheimer’s disease models to stop memory loss. Additional information about Cognition may be found online at http://www.cogrx.com.